3 hours Travere Therapeutics (NASDAQ:TVTX) Stock Price Expected to Rise, Barclays Analyst SaysMarketBeat
Barclays raised their target price on shares of Travere Therapeutics from $18.00 to $20.00 and gave the stock an “overweight” rating in a research report on Friday.
X